Bill Petron

PharmaCielo Q1 2023: Revenue Down 34.2% YoY, CEO Expects Robust Global Sales Of Cannabis Flower In 2023

PharmaCielo FY 2022 Revenue Grows 173%, What About Adjusted EBITDA?

PharmaCielo Q3 Revenue Stagnates, What About Adjusted EBITDA?

PharmaCielo FY 2022 Revenue Grows 173%, What About Adjusted EBITDA?

PharmaCielo Q3 Revenue Stagnates, What About Adjusted EBITDA?

PharmaCielo Ships Dried Cannabis Flower To The Czech Republic, Expanding Its Exports To EU

PharmaCielo Q2 Revenue Soars 375% YoY, Raises Additional $4.6M In Oversubscribed Debenture Financing

PharmaCielo Ships Dried Cannabis Flower To The Czech Republic, Expanding Its Exports To EU

PharmaCielo Q2 Revenue Soars 375% YoY, Raises Additional $4.6M In Oversubscribed Debenture Financing

These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?

PharmaCielo Makes First Shipment Of Cannabinoid Products To Mexican Joint Venture Partner

Bill Petron Recent News

Strategic Cannabis Execs Making Changes At Companies You Know: PharmaCielo, Willow Industries, Delta 9 & More

As Benzinga Cannabis Capital Conference returns (September 13-14) to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the space.

PharmaCielo Ships CBD Full Spectrum Oil To A Brazilian Pharmaceutical Company

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., shipped an initial shipment of a CBD full spectrum extract with THC content

PharmaCielo Q1 Revenue Increases 77.92% YoY, Discusses International Markets

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) Q1 2022 revenue was CA$1.2 million ($947,000) compared to CA$675,000 in Q1 2021, an increase of 77.92%.

PharmaCielo Enters Spanish Market With Initial Shipment Of 300Kg Of CBD Full Spectrum Oil To Extractions Solutions

PharmaCielo Ltd.

PharmaCielo To Enter Polish Medical Cannabis Market Via Partnership With Soteria Holdings

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) parent of PharmaCielo Colombia Holdings S.A.S, has signed an investment agreement with Soteria Holdings Limited.

PharmaCielo Cuts Net Loss By 39.13% To $20.9M Despite Plummeting Revenues In 2021

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announced financial results for the fourth quarter and year ended December 31, 2021

Colombia's Flora Growth & PharmaCielo Begin Exporting Dried Flower As New Rules Take Effect

PharmaCielo Inks First THC Sales Agreement, Will Supply Germany Via Greenstein And NOWEDA

PharmaCielo (OTCQX: PCLOF) will start supplying the German market with three THC-dominant products, with commercial shipments expected to begin in late 2022.

Cannabis Extracts Producer PharmaCielo To Raise $15M Via Private Placement Of Debenture Units

PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) revealed Wednesday that it is in the process of raising up to $15 million through a non-brokered private placement of debenture units.

Cannabis Extracts Producer PharmaCielo's Q3 Revenue Improves 1826% YoY To $380,480

PharmaCielo Ltd. (TSXV: PCLO) (OTCQ: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. announced its financial results on Monday for the third quarter ended September 30, 2021.

PharmaCielo Achieves Colombian GMP Certification For Phytotherapeutics

PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) said Tuesday that it has received Colombian GMP Certification for Phytotherapeutics manufactured with its extracts and proprietary cultivars from the Colombian National Food and Drug Surveillance Institute.